BMAL1 and myocardial ischemia: Because glucose metabolism in cardiomyocytes takes on greater importance under pathologic conditions including myocardial ischemia and hypertrophy, we next investigated the possibility of compensatory induction of the glycolytic pathway in Bmal1−/− hearts.